Last updated on May 2019
XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Percutaneous Transluminal Coronary Angioplasty | Coronary Artery Disease | Coronary heart disease
-
Age: Between 19 - 100 Years
-
Gender: Male or Female
Inclusion Criteria:
- Age 19 and more
- Intervention with XIENCE Xpedition or Alpine or Sierra everolimus eluting coronary stent
- Agreed with written informed consent form
Exclusion Criteria:
- Intervention with XIENCE Xpedition or Alpine or Sierra everolimus eluting coronary stent and other drug eluting stent at the same time
- Life expectancy of 1year and under
- Cardiac shock